Halovate Cream (Halobetasol Cream)0.05%

$7.70

Each Halovate Cream contains .05% Halobetasol is a steroidal medication to treat redness, itching, swelling, and irritation associated with skin conditions

Active Ingrediant: Halobetasol
Generic Name: Halovate Cream
Manufacturer: Glenmark
Strength: 0.05%w/w
Dosage Type: Cream
Packaging Type: Tube in Box
Contains 1 CREAM

Inquire Us

What is this drug used for?

  • It is used to treat skin irritation.
  • It is used to treat skin rashes.
  • It is used to treat plaque psoriasis.

Frequently reported side effects of this drug

  • Dry skin
  • Burning
  • Itching
  • Stinging

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

  • High blood sugar like confusion, fatigue, increased thirst, increased hunger, passing a lot of urine, flushing, fast breathing, or breath that smells like fruit
  • Cushing syndrome like weight gain in upper back or abdomen; moon face; severe headache; or slow healing
  • Adrenal gland problems like severe nausea, vomiting, severe dizziness, passing out, muscle weakness, severe fatigue, mood changes, lack of appetite, or weight loss
  • Skin changes like acne, stretch marks, slow healing, or hair growth
  • Skin thinning
  • Vision changes
  • Severe skin irritation
  • Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Medication Safety Issues

Sound-alike/look-alike issues:

Ultravate may be confused with Cutivate

Storage and Stability

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C and 30°C (59°F to 86°F). Do not freeze.

Foam: Do not refrigerate. Do not expose container to heat and/or store at >49°C (>120°F). Contents are under pressure; do not puncture or incinerate.

Adverse Reactions

Central nervous system: Headache, paresthesia

Dermatologic: Acne vulgaris, leukoderma, local dryness of skin, miliaria, pustules, secondary skin infection, stinging of the skin, telangiectasia, urticaria

Endocrine & metabolic: HPA-axis suppression, hyperglycemia

Local: Application site atrophy, application site burning, application-site dermatitis, application site erythema, application site pain, application-site pruritus, application site rash, application site vesicles

Respiratory: Upper respiratory tract infection

Rare, postmarketing, and/or case reports: Herpes zoster infection, increased blood pressure, influenza, local skin discoloration, nasopharyngitis, otitis media, pharyngitis, skin atrophy, wound